2025-09-14 - Analysis Report
Okay, here's a comprehensive analysis of Colgate-Palmolive (CL) based on the provided data, formatted as requested.

## Colgate-Palmolive (CL) Analysis

**Colgate-Palmolive Co Overview:** Colgate-Palmolive is a global consumer products company focused on oral care, personal care, home care, and pet nutrition.

### 1. Performance vs. S&P 500 (VOO)

**Key Numbers:**

*   **CL Cumulative Return:** 8.11%
*   **VOO Cumulative Return:** 89.18%
*   **Absolute Divergence:** -195.3
*   **Relative Divergence:** 0.2

**Analysis:**

Colgate-Palmolive has significantly underperformed the S&P 500 (VOO) over the analyzed period. The absolute divergence is -195.3, indicating a substantial difference in cumulative returns.  The relative divergence of 0.2 suggests that CL's performance is near the bottom of its historical range relative to the S&P 500.

**Alpha, Beta Analysis Table:**

| Year       | CAGR    | MDD     | Alpha    | Beta   | Cap(B) |
|------------|---------|---------|----------|--------|--------|
| 2015-2017  | 3.0%    | 0.0%    | 0.0%     | -0.2   | 61.0   |
| 2016-2018  | -16.0%   | 65.2%   | -11.0%   | -0.1   | 48.1   |
| 2017-2019  | -2.0%   | 65.2%   | -25.0%   | -0.0   | 55.6   |
| 2018-2020  | 20.0%   | 65.2%   | -7.0%    | 0.0    | 69.1   |
| 2019-2021  | 30.0%   | 58.6%   | -19.0%   | 0.2    | 69.0   |
| 2020-2022  | 8.0%    | 69.0%   | 2.0%     | 0.2    | 63.7   |
| 2021-2023  | 7.0%    | 69.0%   | -13.0%   | 0.9    | 64.4   |
| 2022-2024  | 14.0%   | 69.0%   | -13.0%   | 0.9    | 73.5   |
| 2023-2025  | -2.0%   | 70.6%   | -56.0%   | 0.3    | 67.3   |

**Analysis:**

*   **CAGR:** Fluctuates significantly, with periods of both positive and negative growth.
*   **MDD:** High Maximum Drawdown values suggest significant risk.
*   **Alpha:** Mostly negative, indicating underperformance relative to the market.  The most recent period shows a very negative alpha.
*   **Beta:** Generally low (close to 0 or slightly negative), indicating low correlation with the market.  Recent Beta is higher (0.9), suggesting increasing correlation.
*   **Market Cap:** Relatively stable around the 60-70 Billion dollar range.

### 2. Recent Price Action

**Key Numbers:**

*   **Current Price:** 83.28
*   **Previous Close:** 84.06
*   **Change:** -0.93
*   **5-day Moving Average:** 83.80
*   **20-day Moving Average:** 84.43
*   **60-day Moving Average:** 86.63

**Analysis:**

The stock price is currently below its 5-day, 20-day, and 60-day moving averages, suggesting a short-term downtrend. The change of -0.93 and previous close of 84.06 indicates a recent price decrease.

### 3. Market Risk Indicators and Expected Return

**Key Numbers:**

*   **Market Risk Indicator (MRI):** 0.32 (Low Risk)
*   **RSI:** 37.14 (Approaching Oversold)
*   **PPO:** 0.04
*   **Recent (20-day) Relative Divergence Change:** -1.9 (Negative - Short-term Decline)
*   **Expected Return:** -10894.2%
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (2 shares - Safe - MRI:0.33) (Cash Ratio: 0% on 2025-09-08)

**Analysis:**

*   **MRI:** Indicates a low-risk market environment.
*   **RSI:** Suggests the stock may be approaching oversold territory, potentially indicating a buying opportunity in the near future.
*   **PPO:** Indicates a small change in price momentum.
*   **Relative Divergence Change:** The negative change suggests continued short-term underperformance compared to the S&P 500.
*   **Expected Return:** This is an extremely negative value and likely erroneous/an outlier. This should be investigated further to validate the data. The information may not be reliable.

### 4. Recent News & Significant Events

*   **Positive Sentiment:** Jim Cramer's positive comments ("One of the Premier Consumer Packaged Goods").
*   **Dividend Stability:** Declaration of a regular quarterly dividend indicates financial stability and commitment to shareholder returns.
*   **Productivity Program:** Focus on long-term growth through productivity initiatives.
*   **Passive Income:** Highlighted as a potential source of passive income.
*   **AI Adoption:** Using AI for biomaterials development signals innovation.

**Impact:** The news is generally positive, focusing on the company's stability, shareholder returns, and strategic initiatives.

### 4-2. Analyst Opinions

*   **Consensus:** Buy (Mean: 2.10)
*   **Target Price:** Average target price of $95.22 suggests potential upside from the current price ($83.28).

**Impact:** Analyst ratings provide a generally positive outlook on the stock's future performance.

### 5. Recent Earnings Analysis

| 날짜         | EPS  | 매출        |
|--------------|------|-------------|
| 2025-08-01   | 0.92 | 5.11 B$     |
| 2025-04-25   | 0.85 | 4.91 B$     |
| 2024-10-25   | 0.90 | 5.03 B$     |
| 2024-07-26   | 0.89 | 5.06 B$     |
| 2025-08-01   | 0.89 | 5.06 B$     |

**Analysis:**

*   **EPS:** Shows variability, with a recent increase to 0.92.
*   **Revenue:** Relatively stable around $5 Billion.

**Impact:** Earnings are consistent, with recent improvement in EPS figures.

### 6. Financial Information

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2025-06-30   | $5.11B   | 60.06%        |
| 2025-03-31   | $4.91B   | 60.82%        |
| 2024-12-31   | $4.95B   | 60.30%        |
| 2024-09-30   | $5.03B   | 61.08%        |
| 2024-06-30   | $5.06B   | 60.62%        |

| Quarter      | Equity  | ROE       |
|--------------|---------|------------|
| 2025-06-30   | $0.70B  | 105.84%   |
| 2025-03-31   | $0.36B  | 190.08%   |
| 2024-12-31   | $0.21B  | 348.58%   |
| 2024-09-30   | $0.43B  | 169.43%   |
| 2024-06-30   | $0.12B  | 594.31%   |

**Analysis:**

*   **Revenue:** Stable, indicating consistent demand for products.
*   **Profit Margin:** High and stable around 60%, indicating strong profitability.
*   **Equity:** Fluctuating.
*   **ROE:** Very high, indicating efficient use of equity to generate profits. This is a positive signal but should be validated for consistency and sustainability.

### 7. 종합적인 Analysis(Overall Analysis)

Colgate-Palmolive (CL) shows a mixed picture. It has significantly underperformed the S&P 500. Recent price action suggests a short-term downtrend, but the RSI indicates it is approaching oversold territory. The company benefits from a low-risk market environment (MRI), and recent news is generally positive, emphasizing financial stability and strategic initiatives. Analysts have a "Buy" consensus with a target price suggesting upside potential. Earnings and revenue are relatively stable, with a high profit margin. The ROE is exceptionally high but fluctuates significantly and needs validation. The 'Expected Return' figure appears to be an anomaly and needs verification.

**Key Considerations:**

*   **Underperformance:** The significant underperformance compared to the S&P 500 is a concern.
*   **Valuation:** While analysts see upside, a deeper valuation analysis is needed.
*   **ROE Sustainability:** The very high ROE needs further investigation to ensure it is sustainable.
*   **"Expected Return" Data:** The value of -10894.2% seems inaccurate or should be re-examined to validate the source data.

**Recommendation:**

A cautious approach is warranted. While CL has positive aspects (financial stability, high profit margins, and positive analyst sentiment), the underperformance relative to the market and the short-term downtrend are concerning. Further research is necessary to assess the sustainability of the high ROE and to understand the reasons behind the significant underperformance. If the "Expected Return" data is accurate, it should be addressed as a high priority. Consider a small position if seeking dividend income and stability, but be aware of the potential for continued underperformance.

I hope this detailed analysis is helpful! Let me know if you have any other questions.
